Medtronic reports third quarter fiscal 2025 financial results
Portfolio Pulse from
Medtronic reported its Q3 FY25 financial results, showing a 2.5% increase in revenue to $8.3 billion and a 7% increase in non-GAAP EPS to $1.39. The company highlighted strong performance in several segments and reiterated its full-year guidance.
February 18, 2025 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic's Q3 FY25 results show a 2.5% revenue increase to $8.3 billion and a 7% rise in non-GAAP EPS to $1.39. The company sees strong growth in key segments and maintains its full-year guidance.
Medtronic's financial results indicate strong performance with revenue and EPS growth, particularly in key segments like Cardiac Ablation Solutions. The reiteration of full-year guidance suggests confidence in continued performance, likely positively impacting the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100